5. Cardio 2 Flashcards
A patient has a diagnosis of HOCM, and presents with cerebellar ataxia symptoms, and you notice kyphoscoliosis. What is the most likely diagnosis?
Friedrich’s ataxia
First and second most common causes of sudden cardiac death:
HOCM
ARVD (arrhythmogenic right ventricular cardiomyopathy)
Pathophysiology of ARVD + presentation:
Inherited AD with variable expression
RV myocardium is replaced by fibrous fatty tissue
Palpitations
Syncope
Sudden cardiac death
Investigations and results in ARVD:
ECG - T wave inversion in T1-T3. 50% epsilon wave terminal ‘notch’ on QRS
Echo - enlarged hypokinetic RV with thin free wall
MRI = fibrofatty tissue
Management of ARVD:
Sotalol, which must be avoided in long QT
Catheter ablation to prevent VT
ICD
Pathophysiology of HOCM, which is usually due to a mutation in the beta-myosin heavy chain protein:
AD disorder of contractile protein genes
Left ventricular hypertrophy causes reduced compliance and a reduced cardiac output, diastolic dysfunction.
Disarray and fibrosis is seen on biopsy.
HOCM is often asx, but features can include exertional dyspnoea, angina and syncope, and sudden death. Discuss the pathophysiology of syncope in HOCM:
Subaortic hypertrophy of the ventricular septum causes functional aortic stenosis causing syncope.
Syncope typically follows exercise.
*HOCM asymmetrically affects the heart
Discuss murmurs, echo findings and ECG findings in HOCM:
Ejection systolic murmur due to LVOT obstruction
Increases with valsalva, decreases on squatting
Pansystolic = systolice anterior motion of mitral valve = mitral regurgitation
MR SAM ASH
Drugs to avoid in HOCM:
Nitrates, ACEi, inotropes
They worsen LVOT obstruction
Spectrum of outcomes in HOCM:
Mostly asx
Arrhythmia
Syncope
Mitral regurgitation
Heart failure and symptoms
Sudden cardiac death
Management of HOCM depends on the severity and symptoms. Give some lifestyle advice, and pharmacological / surgical options:
No strenuous exercise
Avoid heavy lifting
Avoid dehydration
BB / verapamil for symptoms
Amiodarone
If at risk of sudden cardiac death = ICD
?Surgical myectomy, alcohol ablation, ?transplant
What is the most common form of cardiomyopathy, including pathophysiology:
Dilated
Dilated heart leading to predominantly systolic dysfunction.
4 chamber dilation, LV > RV.
Features of DCM:
Heart failure symptoms
Systolic murmur - stretching of valves may result in regurgitation
S3
Balloon on CXR
Around 1/3 of patients with DCM are thought to have a genetic predisposition, some due to specific syndromes e.g. DMD, and some familial. What is the inheritance mechanism seen in the majority of cases?
AD
Causes of DCM;
Idiopathic
Viral, coxsackie
IHD
Peripartum
HTN
Doxorubicin
Cocaine
Alcohol
Infiltrative e.g. haemochromatosis, sarcoid
Wet beri beri
3 causes of restrictive cardiomyopathy:
Amyloidosis
Post radiation
Loeffler’s endocarditis
When would peripartum cardiomyopathy typically develop, and give 3 risk factors for its development:
1 month pre delivery and 5 months psot
Older
High parity
Multiple pregnancy
The classifications of cardiomyopathies have changed in recent years. Many causes of dilated cardiomyopathy, among others, are now classed as secondary cardiomyopathy, with types including infective, infiltrative, storage, toxicity, inflammatory, neuromuscular, nutritional deficiency and autoimmune. Group the causes into these headings:
Infective - coxsacki B, HIV, chagas
Infiltrative - amyloidosis
Storage - haemchromatosis
Toxicity - doxorubicin, alcohol
Inflammatory - sarcoidosis
Endocrine - DM, acromegaly, thyroid
Neuromuscular - DMD, Friedrich’s ataxia
Nutritional deficiency - beri beri
Autoimme - SLE
Drug therapy in chronic heart failure:
- BB and ACEi, start separately. (If preserved EF there is no effect on mortality)
- MRA / aldosterone antagonist e.g. spiro / eplerenone, must monitor potassium
+ SGLT2i
- Specialist - ivabridine, ARNI, hydralazine +? nitrate / digoxin
Criteria for starting ivabradine, sacubitril-valsartan, digoxin, hydralazine with nitrate and CRT:
Ivabridine - sinus rhythm >75bpm, LVF <35%
Sacubitril/valsartan ARNI - LVF <35%, symptomatic on acei/arb. Needs acei/arb wash out period
Digoxin - definitely give in coexistant AF. Does not improve mortality but does improve symptoms.
Hydralazine - Afro-caribbean
CRT - widened QRS LBBB on ECG
Causes of chronic heart failure split into cardiac, high-output state and other:
Cardiac; IHD, CMO, HTN, valve disease, pericardial
High output; anaemia, thyrotoxicosis, phaeochromocytoma, liver failure, sepsis, beri-beri, Paget’s,
Other
Alcohol, obesity, cocaine, NSAIDs, BB
3 mechanisms that may explain PND:
Fluid settles over large area during sleep = breathless, resolving when wakes up.
Resp centre in the brain in less reactive during sleep, so resp rate and effort do not increase in response to O2 sats until they’re worse than normal.
Reduced adrenaline during sleep, myocardium relaxed, reduced cardiac output.
You have taken a comprehensive history and examination which gives you high suspicion of chronic heart failure. What is the investigation you will do next, and what will the results lead to?
NT-proBNP
High = >2000 2 week referral
Raised = 400-2000 4 week referral
BNP is produced by myocardium in response to strain.
Very high = poor prognosis.
Describe CRT and when it may be indicated in HF:
<35% ejection fraction.
Biventricular triple chamber pacemakers, with leads to RA,RV and LV. Synchronises the contractions in these chambers to optimise heart function.